PRICE T ROWE ASSOCIATES INC /MD/ - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 69 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2021. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2022$27,000
-20.6%
23,2000.0%0.00%
Q2 2022$34,000
-35.8%
23,2000.0%0.00%
Q1 2022$53,000
+60.6%
23,200
+95.0%
0.00%
Q4 2021$33,000
-81.8%
11,900
-68.0%
0.00%
Q2 2021$181,000
+47.2%
37,200
-25.0%
0.00%
Q1 2021$123,00049,6000.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q3 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders